Playing with Patients?

Gilead Sciences, HIV Antiretrovirals, and the Pursuit of Profit

Over the summer, a series of pharmaceutical product liability actions have been brought to California state courts against Gilead Sciences, Inc., a Bay Area-based pharmaceutical company that researches, develops, and commercializes antiviral drugs used to prevent and manage Human Immunodeficiency Virus-1 (HIV).